New Enterprise Associates 14, L.P.'s Net Worth

$159 Million

Estimate Recalculated Nov 8, 2024 04:38PM EST

Who is New Enterprise Associates 14, L.P.?

New Enterprise Associates 14, L.P. has an estimated net worth of $159 Million. This is based on reported shares across multiple companies, which include MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Mirna Therapeutics, Inc., Cerecor Inc., IMARA Inc., Casper Sleep Inc., ZeroFox Holdings, Inc., Strongbridge Biopharma plc, and INTERLEUKIN GENETICS INC.

SEC CIK

New Enterprise Associates 14, L.P.'s CIK is 0001544328

Past Insider Trading and Trends

2018 was New Enterprise Associates 14, L.P.'s most active year for acquiring shares with 13 total transactions. New Enterprise Associates 14, L.P.'s most active month to acquire stocks was the month of February. 2022 was New Enterprise Associates 14, L.P.'s most active year for disposing of shares, totalling 19 transactions. New Enterprise Associates 14, L.P.'s most active month to dispose stocks was the month of December. 2017 saw New Enterprise Associates 14, L.P. paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 New Enterprise Associates 14, L.P. cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.0644

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.36M
$12.00
—
4.36M
Nov 12
Form 3
—
0
—
—
0
No matching records found

Oyster Point Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.93M
—
—
0
Jan 3
Form 4
+1,737.54%
5.6M
$16.00
—
5.93M
Nov 4
Form 3
—
0
—
—
0
No matching records found

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $1.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.13%
-2.00M
—
—
5.96M
Sep 14
Form 4
-33.45%
-4.00M
—
—
7.96M
Apr 9
Form 4
+0.58%
69.38K
$1.48
$5.64
11.96M
Aug 28
Form 4
+46.07%
3.75M
$4.00
$15,000,000.00
11.89M
Mar 5
Form 4
∞
8.14M
$15.00
—
8.14M
Jul 3
Form 3
—
0
—
—
0
No matching records found

Casper Sleep Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.22M
$6.90
-$42,935,263.80
0
Jan 25
Form 4
+25.14%
1.25M
$12.00
$15,000,000.00
6.22M
Feb 10
Form 3
—
0
—
—
0
No matching records found

IMARA Inc. (ELVN) Snapshot price: $21.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-21.01%
-694.55K
$1.08
-$751,255.76
2.61M
Apr 5 - Apr 6
Form 4
-3.91%
-134.56K
$1.50
-$202,208.87
3.31M
Jan 21 - Jan 25
Form 4
-0.77%
-26.55K
$1.83
-$48,725.97
3.44M
Jan 18 - Jan 20
Form 4
-0.62%
-21.55K
$1.94
-$41,826.49
3.47M
Jan 12 - Jan 14
Form 4
-0.53%
-18.76K
$2.07
-$38,739.78
3.49M
Jan 7 - Jan 11
Form 4
-0.90%
-31.92K
$2.26
-$72,188.58
3.51M
Jan 4 - Jan 6
Form 4
-3.19%
-116.48K
$2.29
-$266,870.49
3.54M
Dec 30 - Jan 3
Form 4
-1.81%
-67.43K
$2.37
-$159,499.83
3.66M
Dec 27 - Dec 29
Form 4
-7.25%
-291.15K
$2.36
-$688,499.19
3.72M
Dec 9 - Dec 23
Form 4
∞
4.01M
$16.00
—
4.01M
Mar 16
Form 3
—
0
—
—
0
No matching records found